Table of Contents
ISRN Obstetrics and Gynecology
Volume 2013, Article ID 814062, 6 pages
http://dx.doi.org/10.1155/2013/814062
Review Article

The Intrauterine Device in Women with Diabetes Mellitus Type I and II: A Systematic Review

1Department of Obstetrics and Gynaecology, Tygerberg Hospital, Western Cape 7505, South Africa
2Reproductive Health and Fertility Regulation, Department of Obstetrics and Gynaecology, Groote Schuur Hospital and University of Cape Town, Cape Town 7925, South Africa

Received 21 September 2013; Accepted 22 October 2013

Academic Editors: L. G. Bahamondes, N. A. Ginsberg, P. G. Larsson, S. Palomba, and J. G. Schenker

Copyright © 2013 Norman D. Goldstuck and Petrus S. Steyn. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. A. Fagot-Campagna, D. J. Pettitt, M. M. Engelgau et al., “Type 2 diabetes among North American children and adolescents: an epidemiologic review and a public health perspective,” Journal of Pediatrics, vol. 136, no. 5, pp. 666–672, 2000. View at Google Scholar · View at Scopus
  2. L. Westrom, L. P. Bengtsson, and P. A. Mardh, “The risk of pelvic inflammatory disease in women using intrauterine contraceptive devices as compared to non users,” The Lancet, vol. 2, no. 7979, pp. 221–224, 1976. View at Google Scholar · View at Scopus
  3. J. M. Steel and L. J. P. Duncan, “Contraception for the insulin-dependent diabetic woman: the view from one clinic,” Diabetes Care, vol. 3, no. 4, pp. 557–560, 1980. View at Google Scholar · View at Scopus
  4. J. Wiese and M. Osler, “Contraception in diabetic patients,” Acta Endocrinologica, vol. 75, no. 182, pp. 87–94, 1974. View at Google Scholar · View at Scopus
  5. J. Wiese, “Intrauterine contraception in diabetic women,” Fertility and Sterility, vol. 28, no. 4, pp. 422–425, 1977. View at Google Scholar · View at Scopus
  6. J. M. Steel, J. Parboosingh, and L. J. Duncan, “Contraception and diabetes,” Diabetes Care, vol. 2, no. 1, p. 60, 1979. View at Google Scholar · View at Scopus
  7. C. Gosden, J. Steel, A. Ross, and A. Springbett, “Intrauterine contraceptive devices in diabetic women,” The Lancet, vol. 1, no. 8271, pp. 530–534, 1982. View at Google Scholar · View at Scopus
  8. B. Larsson, K. Karlsson, and P. K. Liedholm, “Fibrinolytic activity of the endometrium in diabetic women using Cu IUDs,” Contraception, vol. 15, no. 6, pp. 711–716, 1977. View at Google Scholar · View at Scopus
  9. K. H. Kurz and M. Berger, “Intrauterine contraceptive devices for diabetics,” The Lancet, vol. 2, no. 8300, p. 707, 1982. View at Google Scholar · View at Scopus
  10. M. Lawless and M. P. Vessey, “Intrauterine devices for diabetics,” The Lancet, vol. 319, no. 8275, p. 807, 1982. View at Google Scholar
  11. G. M. Craig, “Diabetes, intrauterine devices, and fibrinolysis,” British Medical Journal, vol. 283, no. 6301, p. 1264, 1981. View at Google Scholar · View at Scopus
  12. S. O. Skouby and L. Mølsted-Pedersen, “Intrauterine contraceptive devices for diabetics,” The Lancet, vol. 1, no. 8278, p. 968, 1982. View at Google Scholar · View at Scopus
  13. J. Steel, “IUD use by diabetic women,” British Journal of Family Planning, vol. 8, no. 2, p. 66, 1982. View at Google Scholar
  14. M. Thiery, H. van Kets, K. Kurz, R. Rottiers, and R. Derom, “Intrauterine contraceptive devices for diabetic women,” The Lancet, vol. 2, no. 8303, p. 883, 1982. View at Google Scholar · View at Scopus
  15. G. M. Craig and J. R. Newton, “Contraception in diabetics,” British Medical Journal, vol. 283, no. 6300, p. 1184, 1981. View at Google Scholar · View at Scopus
  16. D. Moher, A. Liberati, J. Tetzlaff, and D. G. Altman, “Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement,” British Medical Journal, vol. 339, Article ID b2535, 2009. View at Publisher · View at Google Scholar · View at Scopus
  17. M. Lawless and M. Vessey, “Intrauterine device use by diabetic women,” British Journal of Family Planning, vol. 7, no. 4, pp. 110–111, 1982. View at Google Scholar · View at Scopus
  18. M. Thiery, H. van Kets, and K. Kurtz, “Are IUD's contraindicated in diabetes?” Tijdschrift voor Geneeskunde, vol. 39, no. 11, pp. 705–707, 1983 (Dutch). View at Google Scholar · View at Scopus
  19. J. A. Elias, “Intra-uterine contraception in diabetic women,” Journal of Obstetrics and Gynaecology, vol. 3, supplement 2, pp. 558–559, 1983. View at Google Scholar
  20. G. M. Craig, “The use of intrauterine contraceptive devices in diabetics,” British Journal of Sexual Medicine, vol. 9, no. 81, pp. 44–48, 1982. View at Google Scholar · View at Scopus
  21. M. Blum, “Gestational diabetes in the past: a relative contraindication for intrauterine contraception,” Advances in Contraception, vol. 1, pp. 131–132, 1985. View at Google Scholar · View at Scopus
  22. D. W. Cramer, I. Schiff, and S. C. Schoenbaum, “Tubal infertility and the intrauterine device,” The New England Journal of Medicine, vol. 312, no. 15, pp. 941–947, 1985. View at Google Scholar · View at Scopus
  23. T. M. M. Farley, M. J. Rosenberg, P. J. Rowe, J.-H. Chen, and O. Meirik, “Intrauterine devices and pelvic inflammatory disease: an international perspective,” The Lancet, vol. 339, no. 8796, pp. 785–788, 1992. View at Publisher · View at Google Scholar · View at Scopus
  24. D. Buchsenschutz, “Non-hormonal methods of contraception in diabetic women: reliability, risks, precautions, surveillance,” Journees Annuelles de Diabetologie de l'Hotel-Dieu, pp. 239–252, 1983 (French). View at Google Scholar · View at Scopus
  25. D. Serfaty, “For and against the IUD in diabetics,” Contraception Fertilite Sexualite, vol. 11, no. 12, pp. 1295–1298, 1983 (French). View at Google Scholar · View at Scopus
  26. S. O. Skouby, L. Molsted-Pedersen, and A. Kosonen, “Consequences of intrauterine contraception in diabetic women,” Fertility and Sterility, vol. 42, no. 4, pp. 568–572, 1984. View at Google Scholar · View at Scopus
  27. R. Kimmerle, R. Weiss, M. Berger, and K.-H. Kurz, “Effectiveness, safety, and acceptability of a copper intrauterine device (CU Safe 300) in type I diabetic women,” Diabetes Care, vol. 16, no. 9, pp. 1227–1230, 1993. View at Google Scholar · View at Scopus
  28. R. Kimmerle, L. Heinemann, and M. Berger, “Intrauterine devices are safe and effective contraceptives for type I diabetic women: further evidence,” Diabetes Care, vol. 18, no. 11, pp. 1506–1507, 1995. View at Google Scholar · View at Scopus
  29. S. L. Kjos, S. A. Ballagh, M. La Cour, A. Xiang, and D. R. Mishell Jr., “The copper T380A intrauterine device in women with type II diabetes mellitus,” Obstetrics and Gynecology, vol. 84, no. 6, pp. 1006–1009, 1994. View at Google Scholar · View at Scopus
  30. O. Grigoryan, E. Grodnitskaya, E. Andreeva, M. Shestakova, G. Melnichenko, and I. Dedov, “Contraception in perimenopausal women with diabetes mellitus,” Gynecological Endocrinology, vol. 22, no. 4, pp. 198–206, 2006. View at Publisher · View at Google Scholar · View at Scopus
  31. K. M. Diab and M. M. Zaki, “Contraception in diabetic women: comparative metabolic study of Norplant, depot medroxyprogesterone acetate, low dose oral contraceptive pill and CuT380A,” Journal of Obstetrics and Gynaecology Research, vol. 26, no. 1, pp. 17–26, 2000. View at Google Scholar · View at Scopus
  32. S. Rogovskaya, R. Rivera, D. A. Grimes et al., “Effect of a levonorgestrel intrauterine system on women with type 1 diabetes: a randomized trial,” Obstetrics and Gynecology, vol. 105, no. 4, pp. 811–815, 2005. View at Publisher · View at Google Scholar · View at Scopus
  33. C. Tietze, “Intrauterine contraception: recommended procedures for data analysis,” Studies in Family Planning, vol. 18, supplement, pp. 1–6, 1967. View at Google Scholar
  34. B. Winner, J. F. Peipert, Q. Zhao et al., “Effectiveness of long-acting reversible contraception,” The New England Journal of Medicine, vol. 366, pp. 1998–2007, 2012. View at Google Scholar
  35. World Health Organisation, Improving Access to Quality Care in Family Planning: Medical Eligibility Criteria for Contraceptive Use, World Health Organisation, Geneva, Switzerland), 2nd edition, 2000.